- Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysisAlex Ward
Center for Epidemiology and Database Analytics, United BioSource Corporation, Lexington, MA 02420, USA
Neuroepidemiology 38:1-17. 2012..The purpose of this study is to summarize and evaluate published estimates for the prevalence of APOE e4 carrier status among the population diagnosed with Alzheimer's disease (AD) by geographic region and country...
- Mild cognitive impairment: disparity of incidence and prevalence estimatesAlex Ward
United BioSource Corporation, Center for Epidemiology and Database Analytics, Lexington, MA, USA
Alzheimers Dement 8:14-21. 2012..The purpose of conducting this study was to identify areas of concordance and sources of variation for the published rates of prevalence and incidence associated with various definitions for mild cognitive impairment (MCI)...
- Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysisSheila Crean
United BioSource Corporation, Lexington, MA 02420, USA
Dement Geriatr Cogn Disord 31:20-30. 2011..The ε4 allele of apolipoprotein E (APOE) is associated with Alzheimer's disease (AD). However, attributable risk due to APOE4 varies by region and by race/ethnicity...